Bergen Brunswig Swallows a Drug Company
- Share via
Bergen Brunswig Corp. said Friday it has completed its acquisition of Pennsylvania-based Stadtlander Drug Co. for about $300 million in cash and stock. The deal represents a major expansion of Orange-based Bergen’s rapidly growing specialty drug business. Stadtlander provides special immune-system medications for patients with HIV and others who have received organ transplants. It also provides pharmaceuticals for about 250,000 inmates in privately operated prisons.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
